ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

PRTG Portage Biotech Inc

0.2402
0.0032 (1.35%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Portage Biotech Inc PRTG NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.0032 1.35% 0.2402 17:23:09
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2418 0.23 0.2642 0.2402 0.237
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
12/4/202407:01GLOBEPortage Biotech Announces Plans to Expand its Evaluation of..
26/3/202407:01GLOBEPortage Biotech Completes Monetization of Intensity..
08/3/202416:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/3/202416:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202416:19EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/2/202416:10GLOBEPortage Biotech Reports Results for Fiscal Quarter Ended..
14/2/202414:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/1/202416:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202407:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/1/202407:00GLOBEPortage Biotech Reports Business and Strategic Update
01/12/202315:05EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/11/202315:03EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
28/11/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/11/202305:00EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
13/11/202305:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/11/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
07/11/202315:50EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/11/202307:01GLOBEPortage Biotech Presents Updates on its iNKT and Adenosine..
31/10/202315:05EDGAR2Form F-1 - Registration statement for certain foreign..
29/9/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/9/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202315:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202315:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/7/202316:12EDGAR2Form 20-F - Annual and transition report of foreign private..

Su Consulta Reciente

Delayed Upgrade Clock